All data are based on the daily closing price as of October 8, 2025
g
GemVax&KAEL
082270.KQ
36.18 USD
-0.89
-2.40%
Overview
Last close
36.18 usd
Market cap
1.29B usd
52 week high
51.11 usd
52 week low
7.31 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
31.367
Price/Book Value
55.091
Enterprise Value
1.62B usd
EV/Revenue
33.7199
EV/EBITDA
-173.0774
Key financials
Revenue TTM
55.33M usd
Gross Profit TTM
13.09M usd
EBITDA TTM
1.61M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
119.93M usd
Net debt
41.36M usd
About
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.